friseb
40.9K posts




Presented at #ACC26: Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: nejm.org/doi/full/10.10… Editorial: Paving the Road toward Targeted Lipid Lowering nejm.org/doi/full/10.10… @ACCinTouch

LiteLLM HAS BEEN COMPROMISED, DO NOT UPDATE. We just discovered that LiteLLM pypi release 1.82.8. It has been compromised, it contains litellm_init.pth with base64 encoded instructions to send all the credentials it can find to remote server + self-replicate. link below


Failure to understand that the fundamental principle of Mendelian randomization (MR) is of gene-environment equivalence contributes to the flood of nonsense MR papers that are appearing; Shah Ebrahim, Gib Hemani and I explain why in this short commentary. journals.plos.org/plosmedicine/a…

💬 Perspective: Bayesian methodology supports efficient, flexible clinical trial designs; FDA guidance encourages prespecification and sensitivity analysis of priors. @f2harrell @d_spiegel ja.ma/47hHTyb
















Introducing agentic trial emulation: Biomni scaled clinical trial emulation using 12M patients EHR data at Mount Sinai. Researchers used Biomni to autonomously emulate multiple landmark anticoagulation RCTs end-to-end within their EHR—turning months of manual target trial analysis into scalable, agent-driven workflows that can extend across large numbers of trials and diseases. Running many emulations in parallel enabled something new: learning a stable institutional transport signal that quantifies how published trial effects systematically translate in local care. Read more: phylo.bio/blog/scaling-a… Exciting work with @BenGlicksberg @joshualampertmd Justin Kauffman et al














